Skip to main content

MoneyWorks4Me

Syschem (India) - Quaterly Results

28 Oct 2026 Evaluate
The September 2026 quarter revenue stood at Rs. 1297.93 millions, up 10.06% as compared to Rs. 1179.24 millions during the corresponding quarter last year.A meek growth of 0.74% was reported for the quarter ended September 2026 to Rs. 19.11  millions from Rs. 18.97 millions.OP of the company witnessed a marginal growth to 44.41 millions from 33.13 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1297.93 1179.24 10.06 2557.41 2446.82 4.52 6546.26 3862.31 69.49
Other Income 0.00 0.11 0.00 0.47 0.16 193.75 0.21 0.42 -50.00
PBIDT 44.41 33.13 34.05 50.34 57.83 -12.95 211.13 40.24 424.68
Interest 7.38 0.10 7280.00 12.28 0.49 2406.12 22.64 0.66 3330.30
PBDT 37.03 33.03 12.11 38.06 57.34 -33.62 188.49 39.58 376.23
Depreciation 15.73 7.57 107.79 31.28 15.14 106.61 40.63 29.47 37.87
PBT 21.30 25.46 -16.34 6.78 42.20 -83.93 147.86 10.11 1362.51
TAX 2.19 6.49 -66.26 4.35 6.49 -32.97 38.58 5.52 598.91
Deferred Tax 2.19 0.00 0.00 4.35 0.00 0.00 38.58 5.52 598.91
PAT 19.11 18.97 0.74 2.43 35.71 -93.20 109.28 4.59 2280.83
Equity 536.16 435.13 23.22 536.16 435.13 23.22 490.13 435.13 12.64
PBIDTM(%) 3.42 2.81 21.79 1.97 2.36 -16.72 3.23 1.04 209.55
Peers
Company Name CMP
Sun Pharma. Inds. 1757.20
Dr. Reddys Labs. 1340.15
Cipla 1357.70
Lupin 1987.50
Zydus Lifesciences 1174.10
View more..